Levenfors J, Bjerketorp J, Guss B, Nord C, Cao S, Hughes D
J Antimicrob Chemother. 2024; 80(2):509-517.
PMID: 39688409
PMC: 11787897.
DOI: 10.1093/jac/dkae438.
Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Georgiades B
Antimicrob Agents Chemother. 2022; 66(10):e0061822.
PMID: 36154614
PMC: 9578435.
DOI: 10.1128/aac.00618-22.
Lasko M, Gethers M, Tabor-Rennie J, Nicolau D, Kuti J
Antimicrob Agents Chemother. 2022; 66(3):e0216721.
PMID: 35007135
PMC: 8923228.
DOI: 10.1128/aac.02167-21.
Liang K, Abt E, Le T, Cho A, Dann A, Cui J
Proc Natl Acad Sci U S A. 2021; 118(36.
PMID: 34480004
PMC: 8433573.
DOI: 10.1073/pnas.2105390118.
Nakamura R, Oota M, Matsumoto S, Sato T, Yamano Y
Antimicrob Agents Chemother. 2021; 65(4).
PMID: 33526491
PMC: 8097474.
DOI: 10.1128/AAC.01436-20.
Comparative Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against in the Murine Thigh Model.
Chen I, Kidd J, Abdelraouf K, Nicolau D
Antimicrob Agents Chemother. 2019; 63(12).
PMID: 31591126
PMC: 6879223.
DOI: 10.1128/AAC.01558-19.
Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model.
Huang D, Park J, Murphy T
Eur J Clin Microbiol Infect Dis. 2018; 38(2):409-412.
PMID: 30483998
DOI: 10.1007/s10096-018-3440-2.
Identification of the Pharmacokinetics and Pharmacodynamic Driver of Iclaprim.
Park J, Craig W, Marchillo K, Huang D, Andes D
Antimicrob Agents Chemother. 2018; 62(4).
PMID: 29378717
PMC: 5913961.
DOI: 10.1128/AAC.02550-17.
Identification of Staphylococcus aureus Factors Required for Pathogenicity and Growth in Human Blood.
Connolly J, Boldock E, Prince L, Renshaw S, Whyte M, Foster S
Infect Immun. 2017; 85(11).
PMID: 28808156
PMC: 5649012.
DOI: 10.1128/IAI.00337-17.
The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice.
Wiehr S, Rolle A, Warnke P, Kohlhofer U, Quintanilla-Martinez L, Reischl G
PLoS One. 2016; 11(10):e0164163.
PMID: 27701464
PMC: 5049782.
DOI: 10.1371/journal.pone.0164163.
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
Kim W, Le T, Wei L, Poddar S, Bazzy J, Wang X
Proc Natl Acad Sci U S A. 2016; 113(15):4027-32.
PMID: 27035974
PMC: 4839461.
DOI: 10.1073/pnas.1524212113.
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer.
Calvo E, Chen V, Marshall M, Ohnmacht U, Hynes S, Kumm E
Invest New Drugs. 2014; 32(5):955-68.
PMID: 24942404
DOI: 10.1007/s10637-014-0114-5.
Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee S, Yeo J, Lee H, Lee E, Kim S, Jang S
Eur J Nucl Med Mol Imaging. 2014; 41(7):1327-35.
PMID: 24562648
DOI: 10.1007/s00259-014-2712-z.
Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.
Campbell D, Yaghoubi S, Su Y, Lee J, Auerbach M, Herschman H
J Biol Chem. 2011; 287(1):446-454.
PMID: 22074768
PMC: 3249097.
DOI: 10.1074/jbc.M111.314666.
Aerococcus urinae and trimethoprim-sulfamethoxazole.
Humphries R, Lee C, Hindler J
J Clin Microbiol. 2011; 49(11):3934-5.
PMID: 21918023
PMC: 3209118.
DOI: 10.1128/JCM.05535-11.
PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.
Nair-Gill E, Wiltzius S, Wei X, Cheng D, Riedinger M, Radu C
J Clin Invest. 2010; 120(6):2005-15.
PMID: 20484820
PMC: 2877561.
DOI: 10.1172/JCI41250.
Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.
Zander J, Besier S, Ackermann H, Wichelhaus T
Antimicrob Agents Chemother. 2009; 54(3):1226-31.
PMID: 20028816
PMC: 2826018.
DOI: 10.1128/AAC.00705-09.
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
Entenza J, Haldimann A, Giddey M, Lociuro S, Hawser S, Moreillon P
Antimicrob Agents Chemother. 2009; 53(9):3635-41.
PMID: 19564362
PMC: 2737851.
DOI: 10.1128/AAC.00325-09.
Tuberculosis and trimethoprim-sulfamethoxazole.
Forgacs P, Wengenack N, Hall L, Zimmerman S, Silverman M, Roberts G
Antimicrob Agents Chemother. 2009; 53(11):4789-93.
PMID: 19564358
PMC: 2772331.
DOI: 10.1128/AAC.01658-08.
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
Barth R, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S
Proc Natl Acad Sci U S A. 2008; 105(45):17493-7.
PMID: 18981415
PMC: 2582264.
DOI: 10.1073/pnas.0809569105.
